GSK
GSK
GSK ir globāls veselības aprūpes un farmācijas uzņēmums, kas apvieno zinātniskos pētījumus, tehnoloģijas un specializētu talantu, lai izstrādātu zāles un vakcīnas. Uzņēmuma darbība aptver slimību profilaksei un ārstēšanai paredzētu produktu atklāšanu, ražošanu un piegādi, piedāvājot iespējas sniegt ieguldījumu veselības aprūpes inovācijās lielā starptautiskā organizācijā.

Director, Clinical Operations Asset Lead, Late-Phase Lung Oncology

Lead global late-phase lung oncology programs at GSK, shaping clinical operations strategy and study delivery. Oversee risk management, operational planning, and readiness for a Biologics License Application (BLA).

Apraksts

  • Lead clinical operations strategy and end-to-end asset delivery from candidate commitment through development, late-phase execution, and lifecycle management.
  • Shape the Clinical Development Plan and Integrated Evidence Plan.
  • Plan asset operations and model scenarios, balancing timelines, costs, resources, quality, and risk.
  • Set the asset resourcing strategy, including insourcing and outsourcing decisions, vendor selection, and oversight of external delivery partners.
  • Provide strategic leadership to Study Delivery Teams.
  • Coordinate cross-functional expertise and serve as the senior escalation point for significant operational, quality, and delivery issues.
  • Lead asset-level risk management, quality, and inspection readiness.
  • Apply Quality by Design principles and mitigate operational and GCP-related risks.
  • Lead operational strategies for country selection, patient engagement, diversity, and study execution.
  • Bring innovation, technology, and external insights into asset delivery.
  • Maintain strong financial, data, and stakeholder governance.
  • Oversee budget forecasts, operational data, regulatory submission contributions, and communications across clinical operations and asset stakeholders.

Prasības

  • Bachelor’s degree in life sciences, healthcare, business, or a related field, or equivalent experience.
  • At least 10 years of pharmaceutical R&D or related industry experience.
  • At least 3 years as a Clinical Operations Asset Lead (COAL) or in a similar role focused on lung cancer indications.
  • At least 5 years successfully managing complex global programs involving multiple studies.
  • Experience preparing for and completing a BLA filing, including early preparation and inspection readiness.
  • Deep therapeutic-area expertise and strong knowledge of lung treatments and the competitive landscape.
  • A relevant advanced degree (Master’s, PhD, PharmD, or MD) is preferred.
  • Fluency in using AI in day-to-day work to accelerate trial timelines, improve data quality and evidence assurance, and reduce manual work is preferred.
  • Experience leading global portfolios or cross-region evidence programs is preferred.
  • Strong data fluency, including using dashboards and performance metrics to inform decisions, is preferred.
  • Experience overseeing vendors and partnering with CROs, academic networks, or external investigators is preferred.
  • A track record of process improvement or digitally enabled transformation in evidence generation is preferred.

Priekšrocības

  • Annual bonus.
  • Eligibility to participate in a share-based long-term incentive program.
  • Health care and other insurance benefits for employees and their families.
  • Retirement benefits.
  • Paid holidays.
  • Vacation.
  • Paid caregiver, parental, and medical leave.
  • Comprehensive benefits program.
  • Accommodation or other assistance during the job application process.

Saistītās vakances

RSM US LLP

Clinical Operations Manager, Healthcare Consulting

RSM US LLP

Lead clinical operations assessments and performance improvement projects for hospitals and health systems. Develop practical recommendations, executive presentations, and implementation plans.

Atvērt